Resources for Food and Drug Administration (FDA)

Facing 5,000 Lawsuits, Hormone Maker Wyeth Says It Resents FDA Intervention

ww.bestsyndication.com

The Food and Drug Administration is starting to act like a watchdog not a lapdog says outgoing chief executive officer of Wyeth Bob Essner and it's no fair.

Not only has the FDA failed to approve three new Wyeth drugs designed to replace Effexor revenues when its patent expires in 2010--Viviant, for osteoporosis, Pristiq, for depression and menopause and bifeprunox for schizophrenia--it dared to compare their benefit/risk profile to drugs already on the market, challenging the Pharma received wisdom that newer equals better.

View the Resource

Share or bookmarklet this web page at: